Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1991 Nov;65(11):6371–6375. doi: 10.1128/jvi.65.11.6371-6375.1991

Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages.

J L Lathey 1, S A Spector 1
PMCID: PMC250364  PMID: 1656103

Abstract

Monocytes differentiated in the presence of phytohemagglutinin P-stimulated T cells could be infected with human cytomegalovirus AD169 and produced low levels of infectious virus. Additional treatment with therapeutic levels of hydrocortisone resulted in a 10- to 100-fold increase in infectious virus production. Hydrocortisone-treated cells demonstrated immediate-early protein kinetics similar to that observed with human fibroblasts, whereas a delay of up to 24 h was observed with untreated cells. Late protein production was barely detectable by immunostaining without hydrocortisone treatment. In treated cells, however, late protein was detected and the levels correlated with the number of cells producing infectious virus. This system provides a model for human cytomegalovirus infection of macrophages in humans.

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betts R. F. Cytomegalovirus infection in transplant patients. Prog Med Virol. 1982;28:44–64. [PubMed] [Google Scholar]
  2. Dankner W. M., McCutchan J. A., Richman D. D., Hirata K., Spector S. A. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis. 1990 Jan;161(1):31–36. doi: 10.1093/infdis/161.1.31. [DOI] [PubMed] [Google Scholar]
  3. Dudding L. R., Garnett H. M. Interaction of strain AD169 and a clinical isolate of cytomegalovirus with peripheral monocytes: the effect of lipopolysaccharide stimulation. J Infect Dis. 1987 May;155(5):891–896. doi: 10.1093/infdis/155.5.891. [DOI] [PubMed] [Google Scholar]
  4. Forbes B. A., Bonville C. A., Dock N. L. The effects of a promoter of cell differentiation and selected hormones on human cytomegalovirus infection using an in vitro cell system. J Infect Dis. 1990 Jul;162(1):39–45. doi: 10.1093/infdis/162.1.39. [DOI] [PubMed] [Google Scholar]
  5. Gerrard T. L., Cupps T. R., Jurgensen C. H., Fauci A. S. Increased expression of HLA-DR antigens in hydrocortisone-treated monocytes. Cell Immunol. 1984 Apr 1;84(2):311–316. doi: 10.1016/0008-8749(84)90102-3. [DOI] [PubMed] [Google Scholar]
  6. Gnann J. W., Jr, Ahlmén J., Svalander C., Olding L., Oldstone M. B., Nelson J. A. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol. 1988 Aug;132(2):239–248. [PMC free article] [PubMed] [Google Scholar]
  7. Goldstein L. C., McDougall J., Hackman R., Meyers J. D., Thomas E. D., Nowinski R. C. Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun. 1982 Oct;38(1):273–281. doi: 10.1128/iai.38.1.273-281.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gönczöl E., Andrews P. W., Plotkin S. A. Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science. 1984 Apr 13;224(4645):159–161. doi: 10.1126/science.6322309. [DOI] [PubMed] [Google Scholar]
  9. Honma Y., Kasukabe T., Hozumi M. Structure requirements and affinity of steroids to bind with receptor for induction of differentiation of cultured mouse myeloid leukemia cells. Gan. 1977 Aug;68(4):405–412. [PubMed] [Google Scholar]
  10. Jacobson M. A., Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med. 1988 Apr;108(4):585–594. doi: 10.7326/0003-4819-108-4-585. [DOI] [PubMed] [Google Scholar]
  11. Koment R. W. Lytic cytomegalovirus replication and the hormones of human pregnancy. J Med Virol. 1985 Feb;15(2):149–156. doi: 10.1002/jmv.1890150207. [DOI] [PubMed] [Google Scholar]
  12. Koment R. W. Restriction to human cytomegalovirus replication in vitro removed by physiological levels of cortisol. J Med Virol. 1989 Jan;27(1):44–47. doi: 10.1002/jmv.1890270110. [DOI] [PubMed] [Google Scholar]
  13. Nelson J. A., Gnann J. W., Jr, Ghazal P. Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol. 1990;154:75–100. doi: 10.1007/978-3-642-74980-3_4. [DOI] [PubMed] [Google Scholar]
  14. Pasquale D., Chikkappa G., Wang G., Santella D. Hydrocortisone promotes survival and proliferation of granulocyte-macrophage progenitors via monocytes/macrophages. Exp Hematol. 1989 Dec;17(11):1110–1115. [PubMed] [Google Scholar]
  15. Rice G. P., Schrier R. D., Oldstone M. B. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A. 1984 Oct;81(19):6134–6138. doi: 10.1073/pnas.81.19.6134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Saltzman R. L., Quirk M. R., Jordan M. C. Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest. 1988 Jan;81(1):75–81. doi: 10.1172/JCI113313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schrier R. D., Nelson J. A., Oldstone M. B. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science. 1985 Nov 29;230(4729):1048–1051. doi: 10.1126/science.2997930. [DOI] [PubMed] [Google Scholar]
  18. Stosić-Grujicić S., Simić M. M. Modulation of interleukin 1 production by activated macrophages: in vitro action of hydrocortisone, colchicine, and cytochalasin B. Cell Immunol. 1982 May 15;69(2):235–247. doi: 10.1016/0008-8749(82)90070-3. [DOI] [PubMed] [Google Scholar]
  19. Strickland R. W., Wahl L. M., Finbloom D. S. Corticosteroids enhance the binding of recombinant interferon-gamma to cultured human monocytes. J Immunol. 1986 Sep 1;137(5):1577–1580. [PubMed] [Google Scholar]
  20. Szefler S. J., Norton C. E., Ball B., Gross J. M., Aida Y., Pabst M. J. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming. J Immunol. 1989 Jun 1;142(11):3985–3992. [PubMed] [Google Scholar]
  21. Tanaka J., Ogura T., Kamiya S., Sato H., Yoshie T., Ogura H., Hatano M. Enhanced replication of human cytomegalovirus in human fibroblasts treated with dexamethasone. J Gen Virol. 1984 Oct;65(Pt 10):1759–1767. doi: 10.1099/0022-1317-65-10-1759. [DOI] [PubMed] [Google Scholar]
  22. Turtinen L. W., Saltzman R., Jordan M. C., Haase A. T. Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog. 1987 Oct;3(4):287–297. doi: 10.1016/0882-4010(87)90062-3. [DOI] [PubMed] [Google Scholar]
  23. Velasco N., Catto G. R., Edward N., Engeset J., Moffat M. A. The effect of the dosage of steroids on the incidence of cytomegalovirus infections in renal transplant recipients. J Infect. 1984 Jul;9(1):69–78. doi: 10.1016/s0163-4453(84)94576-6. [DOI] [PubMed] [Google Scholar]
  24. Weinshenker B. G., Wilton S., Rice G. P. Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol. 1988 Mar 1;140(5):1625–1631. [PubMed] [Google Scholar]
  25. Wentworth B. B., French L. Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med. 1970 Nov;135(2):253–258. doi: 10.3181/00379727-135-35031. [DOI] [PubMed] [Google Scholar]
  26. Zanker B., Walz G., Wieder K. J., Strom T. B. Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells. Transplantation. 1990 Jan;49(1):183–185. doi: 10.1097/00007890-199001000-00040. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES